What do systematic reviews say?

Switch to a specific antipsychotic vs switch to a different specific antipsychotic

• Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  7 studies · 466 participants
  Very low

Specific antipsychotic vs other drugs

It is very uncertain whether specific antipsychotic changes acceptability of the treatment: leaving the study early compared with other drugs (very low certainty).

• Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia 2018 · Cochrane Headline outcomes only
  RR 4.38 [0.25, 76.54]
  1 study · 13 participants
  Very low

Reduced dose of antipsychotics vs antipsychotic maintenance

It is very uncertain whether reduced dose of antipsychotics changes acceptability of the treatment: leaving the study early compared with antipsychotic maintenance (very low certainty).

• Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia 2018 · Cochrane Headline outcomes only
  RR 0.33 [0.06, 1.99]
  1 study · 8 participants
  Very low

Switch to another antipsychotic vs antipsychotic cessation

It is very uncertain whether switch to another antipsychotic changes acceptability of the treatment: leaving the study early compared with antipsychotic cessation (very low certainty).

• Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia 2018 · Cochrane Headline outcomes only
  RR 0.6 [0.16, 2.25]
  1 study · 50 participants
  Very low